Lupus and Lupus Nephritis: Improving Outcomes and Reducing Disparities

Join us for this interactive 1-hour webinar on recent advances in systemic lupus erythematosus (SLE) and lupus nephritis. Rheumatologist  Karen H. Costenbader, MD, MPH and nephrologist Brad H. Rovin, MD will bring you up to date on diagnosing SLE, screening for nephritis, latest approaches to management, and addressing disparities in care.

Agenda

Welcome and Introduction

Identifying and Managing SLE

Karen H. Costenbader, MD, MPH

Lupus Nephritis: Screening and Evaluation

Brad H. Rovin, MD

Recent Advances in Managing Lupus Nephritis

Brad H. Rovin, MD

Health Disparities in SLE and Lupus Nephritis

Karen H. Costenbader, MD, MPH

Q&A

Events

Date / Time
Event Details

Faculty

Faculty
Karen H. Costenbader, MD, MPH

Professor of Medicine
Department of Medicine
Harvard Medical School
Director, Lupus Program
Division of Rheumatology, Inflammation and Immunity
Brigham and Women's Hospital
Boston, Massachusetts

Faculty
Brad H. Rovin, MD

Professor and Director, Division of Nephrology
The Lee A. Hebert Professor of Nephrology
Medical Director
, The Ohio State Center for Clinical Research Management
The Ohio State University Wexner Medical Center
Columbus, Ohio

Program Overview
This program will provide healthcare providers with an update on recent advances in SLE and LN, including diagnosis of SLE, screening for LN, management of SLE and LN, and addressing health disparities that may affect patients with SLE/LN.

Goal Statement
The goal of this initiative is to improve the knowledge and competence of learners in rheumatology and nephrology settings regarding the management of SLE and LN, including the management of patients with SLE/LN affected by health disparities.

Target Audience
This program is intended for rheumatologists, nephrologists, primary care physicians, physician assistants, nurse practitioners, and other healthcare professionals who care for patients with SLE. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify patients with SLE
  • Implement LN screenings in patients with SLE
  • Summarize recent advances regarding the appropriate use of available and emerging therapies for SLE and LN
  • Detail strategies to reduce health disparities affecting patients with SLE and LN

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.